Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Annals of Medicine|December 8, 2023
Predictive value of immunotherapy-induced inflammation indexes: dynamic changes in patients with nasopharyngeal carcinoma receiving immune checkpoint inhibitorsJiaxin Cao, Qun Chen, Xue Bai, et al.Medcomm|June 4, 2024
Influence of TP53 mutation on efficacy and survival in advanced EGFR-mutant non-small cell lung cancer patients treated with third-generation EGFR tyrosine kinase inhibitorsZhonghan Zhang, Jinhui Xue, Yunpeng Yang, et al.Therapeutic Advances in Medical Oncology|January 8, 2020
Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysisZhonghan Zhang, Kangmei Zeng, Shen Zhao, et al.Annals of Translational Medicine|November 9, 2019
Multi-targeted tyrosine kinase inhibitors as third-line regimen in advanced non-small cell lung cancer: a network meta-analysisZhonghan Zhang, Yuanyuan Zhao, Feiteng Lu, et al.Cellular & Molecular Immunology|December 7, 2023
The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activationFan Luo, Han Li, Wenjuan Ma, et al.Pageof 2